Three local firms' shares emerging as higher growth potential this year

Published: 2004-03-04 06:59:00

Updated: 2004-03-04 06:59:00

With the prevailing prediction that Korea's gross domestic product in 2004 will reach at a 4.8 percent mark while drug's shipment index and output will hover at 8.1 percent and 4.9 percent, respectively, Shinheung Securities company said in its recent report that shares of three firms, such as Yu...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK